HF
NTUS

HRT Financial’s Natus Medical Inc NTUS Stock Holding History

HRT Financial’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,145
Closed -$445K – 3956
2021
Q2 		$445K Buy
+17,145
New +$466K ﹤0.01% 1884
2020
Q4 		– Sell
-10,297
Closed -$176K – 2704
2020
Q3 		$176K Buy
+10,297
New +$195K 0.01% 1401

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HRT Financial's NTUS Position: Q3 2021 in Review

HRT Financial sold out of Natus Medical Inc (NTUS) in Q3 2021, closing a stake of 17,145 shares — an estimated $445K sold.

HRT Financial first reported a position in NTUS in Q3 2020 and held it in 2 quarters. The position peaked at $445K in Q2 2021. 169 funds tracked by Wall St. Rank hold NTUS as of Q3 2021.

  • HRT Financial reported no remaining Natus Medical Inc position as of Q3 2021 after selling out during the quarter.
  • HRT Financial sold 17,145 Natus Medical Inc shares in Q3 2021, an estimated $445K.
  • HRT Financial first reported a position in Natus Medical Inc in Q3 2020 and held it in 2 quarters.
  • HRT Financial's Natus Medical Inc position peaked at $445K in Q2 2021.
  • 169 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2021.

Based on HRT Financial's 13F filing for Q3 2021, filed 15 Nov 2021.